These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9449532)

  • 21. HIV-1 rev nuclear export signal binding peptides isolated by phage display.
    Jensen A; Jensen TH; Kjems J
    J Mol Biol; 1998; 283(1):245-54. PubMed ID: 9761687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.
    Fang J; Acheampong E; Dave R; Wang F; Mukhtar M; Pomerantz RJ
    Virology; 2005 Jun; 336(2):299-307. PubMed ID: 15892970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct export pathway utilized by the hepatitis B virus posttranscriptional regulatory element.
    Zang WQ; Yen TS
    Virology; 1999 Jul; 259(2):299-304. PubMed ID: 10388654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
    Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
    J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of cis-acting repressor activity within human immunodeficiency virus type 1 protease sequences.
    Huffman KM; Arrigo SJ
    Virology; 1997 Aug; 234(2):253-60. PubMed ID: 9268156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleocytoplasmic RNA transport in retroviral replication.
    Wodrich H; Kräusslich HG
    Results Probl Cell Differ; 2001; 34():197-217. PubMed ID: 11288676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retroviral RNA elements integrate components of post-transcriptional gene expression.
    Boris-Lawrie K; Roberts TM; Hull S
    Life Sci; 2001 Oct; 69(23):2697-709. PubMed ID: 11720075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthus niruri.
    Qian-Cutrone J; Huang S; Trimble J; Li H; Lin PF; Alam M; Klohr SE; Kadow KF
    J Nat Prod; 1996 Feb; 59(2):196-9. PubMed ID: 8991954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus type 1 Rev-dependent effects on the late gene expression of recombinant human adenovirus.
    Williams RD; Leppard KN
    Virus Genes; 1996; 13(2):111-20. PubMed ID: 8972565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs.
    Fischer U; Huber J; Boelens WC; Mattaj IW; Lührmann R
    Cell; 1995 Aug; 82(3):475-83. PubMed ID: 7543368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of small, therapeutic RNAs in human cell nuclei.
    Good PD; Krikos AJ; Li SX; Bertrand E; Lee NS; Giver L; Ellington A; Zaia JA; Rossi JJ; Engelke DR
    Gene Ther; 1997 Jan; 4(1):45-54. PubMed ID: 9068795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttranscriptional regulation by Rev protein of human immunodeficiency virus type 1 results in nonrandom nuclear localization of gag mRNA.
    Romanov VI; Zolotukhin AS; Aleksandroff NN; Pinto da Silva P; Felber BK
    Virology; 1997 Feb; 228(2):360-70. PubMed ID: 9123843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hepatitis B virus posttranscriptional regulatory element contains a highly stable RNA secondary structure.
    Patzel V; Sczakiel G
    Biochem Biophys Res Commun; 1997 Feb; 231(3):864-7. PubMed ID: 9070912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs.
    Yedavalli VS; Jeang KT
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14787-92. PubMed ID: 20679221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector.
    Inouye RT; Du B; Boldt-Houle D; Ferrante A; Park IW; Hammer SM; Duan L; Groopman JE; Pomerantz RJ; Terwilliger EF
    J Virol; 1997 May; 71(5):4071-8. PubMed ID: 9094685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenylcoumarin with Rev-export inhibitory activity from Cnidii Monnieris Fructus.
    Tamura S; Fujitani T; Kaneko M; Murakami N
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3717-20. PubMed ID: 20493693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative study of the control of HIV-1 gene expression.
    Hammond BJ
    J Theor Biol; 1993 Jul; 163(2):199-221. PubMed ID: 8246504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus type 1 Rev function requires continued synthesis of its target mRNA.
    Iacampo S; Cochrane A
    J Virol; 1996 Dec; 70(12):8332-9. PubMed ID: 8970952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.